2-74490044-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_022492.6(TTC31):c.149G>A(p.Arg50Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000118 in 1,561,912 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_022492.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TTC31 | NM_022492.6 | c.149G>A | p.Arg50Gln | missense_variant | 3/13 | ENST00000233623.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TTC31 | ENST00000233623.11 | c.149G>A | p.Arg50Gln | missense_variant | 3/13 | 1 | NM_022492.6 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000396 AC: 6AN: 151696Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000568 AC: 10AN: 176048Hom.: 0 AF XY: 0.0000320 AC XY: 3AN XY: 93766
GnomAD4 exome AF: 0.000127 AC: 179AN: 1410216Hom.: 0 Cov.: 35 AF XY: 0.000105 AC XY: 73AN XY: 696798
GnomAD4 genome AF: 0.0000396 AC: 6AN: 151696Hom.: 0 Cov.: 32 AF XY: 0.0000405 AC XY: 3AN XY: 74048
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 13, 2023 | The c.149G>A (p.R50Q) alteration is located in exon 3 (coding exon 3) of the TTC31 gene. This alteration results from a G to A substitution at nucleotide position 149, causing the arginine (R) at amino acid position 50 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at